Chargement en cours...
Fingolimod promotes blood–nerve barrier properties in vitro
OBJECTIVE: The main effect of fingolimod is thought to be functional antagonism of lymphocytic S1P1 receptors and the prevention of lymphocyte egress from lymphoid tissues, thereby reducing lymphocyte infiltration into the nervous system. However, a growing number of reports suggest that fingolimod...
Enregistré dans:
| Publié dans: | Brain Behav |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5893339/ https://ncbi.nlm.nih.gov/pubmed/29670818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.924 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|